PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) explained in plain language.

Never miss a new study

Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) trials appear

Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New hope for Tough-to-Treat leukemias: experimental combo enters human testing

Disease control Recruiting now

This early-stage study is testing the safety and best dose of a new drug, ABL001, when combined with three existing leukemia medications. It is for adults with two specific, aggressive types of blood cancer (BCR-ABL+ B-ALL or CML in blast crisis). The main goal is to see if this …

Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Phase: PHASE1 • Sponsor: Marlise Luskin, MD • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)

Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) trials appear

New hope for Tough-to-Treat leukemias: experimental combo enters human testing